DA
VCYT icon

Duality Advisers’s Veracyte VCYT Stock Holding History

Duality Advisers’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-48,773
Closed -$1.09M – 746
2023
Q1 		$1.09M Buy
48,773
+9,317
+24% +$225K 0.12% 287
2022
Q4 		$936K Buy
+39,456
New +$917K 0.11% 329

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Duality Advisers's VCYT Position: Q2 2023 in Review

Duality Advisers sold out of Veracyte (VCYT) in Q2 2023, closing a stake of 48,773 shares — an estimated $1.09M sold.

Duality Advisers first reported a position in VCYT in Q4 2022 and held it in 2 quarters. The position peaked at $1.09M in Q1 2023. 232 funds tracked by Wall St. Rank hold VCYT as of Q2 2023.

  • Duality Advisers reported no remaining Veracyte position as of Q2 2023 after selling out during the quarter.
  • Duality Advisers sold 48,773 Veracyte shares in Q2 2023, an estimated $1.09M.
  • Duality Advisers first reported a position in Veracyte in Q4 2022 and held it in 2 quarters.
  • Duality Advisers's Veracyte position peaked at $1.09M in Q1 2023.
  • 232 funds tracked by Wall St. Rank held Veracyte as of Q2 2023.

Based on Duality Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.